Norisodrine with Calcium Iodine Disease Interactions
There are 4 disease interactions with Norisodrine with Calcium Iodine (anhydrous calcium iodide / isoproterenol).
Isopreterenol (applies to Norisodrine with Calcium Iodine) tachyarrhythmias
Major Potential Hazard, Moderate plausibility. Applicable conditions: Angina Pectoris
The use of isoproterenol is contraindicated in patients with tachyarrhythmias; tachycardia or heart block caused by digitalis intoxication; ventricular arrhythmias which require inotropic therapy; and angina pectoris.
References (1)
- (2001) "Product Information. Isuprel (isoproterenol)." Sanofi Winthrop Pharmaceuticals
Sympathomimetics (applies to Norisodrine with Calcium Iodine) dehydration
Major Potential Hazard, High plausibility.
The use of sympathomimetic amines has been infrequently associated with significant hypotension especially in dehydrated patients secondary to the drug's beta-2 mediated vasodilation. Hypovolemia should be corrected, if possible, before administering sympathomimetic amines. Blood pressure and ECG should be monitored at regular intervals. Monitoring of cardiac output and pulmonary wedge pressure may also be desired.
References (4)
- (2001) "Product Information. Isuprel (isoproterenol)." Sanofi Winthrop Pharmaceuticals
- (2022) "Product Information. Epifrin (EPINEPHrine ophthalmic)." Allergan Inc
- (2022) "Product Information. Adrenalin (EPINEPHrine)." Apothecon Inc
- (2001) "Product Information. Levophed Bitartrate (norepinephrine)." Sanofi Winthrop Pharmaceuticals
Iodide salts (applies to Norisodrine with Calcium Iodine) hyperthyroidism
Moderate Potential Hazard, Low plausibility.
The use of iodide salts has been associated with the exacerbation or precipitation of hyperthyroidism in patients previously euthyroid. Induction of goiter has been reported in patients with hyperthyroidism. Iodide salts should be administered cautiously in patients with hyperthyroidism.
References (8)
- Iancu T, Boyanower Y, Laurian N (1974) "Congenital goiter due to maternal ingestion of iodide." Am J Dis Child, 128, p. 528-30
- Ayromlooi J (1972) "Congenital goiter due to maternal ingestion of iodides." Obstet Gynecol, 39, p. 818-22
- Denham MJ, Himsworth RL (1974) "Hyperthyroidism induced by potassium iodide given in the course of 125I-fibrinogen test." Age Ageing, 3, p. 221-5
- Yalow RS (1983) "Risks in mass distribution of potassium iodide." Bull N Y Acad Med, 59, p. 1020-7
- "Product Information. SSKI (saturated) (potassium iodide)." Upsher-Smith Laboratories Inc
- (2022) "Product Information. Pima (potassium iodide)." Fleming and Company
- Carswell F, Kerr MM, Hutchison JH (1970) "Congenital goitre and hypothyroidism produced by maternal ingestion of iodides." Lancet, 1, p. 1241-3
- Parmelle A, et al. (1940) "Three cases of newborn infants with congential goiter due to ingestion of iodide." Am J Obstet Gynecol, 40, p. 145-7
Sympathomimetics (applies to Norisodrine with Calcium Iodine) acidosis
Moderate Potential Hazard, High plausibility.
Acidosis, hypoxia, and hypercapnia may reduce the effectiveness of sympathomimetic amines in raising blood pressure. These conditions should be corrected before initiating therapy with sympathomimetic amines, if possible. Monitoring the patients acid-base balance, carbon dioxide levels, and oxygen saturation is recommended.
References (4)
- (2001) "Product Information. Isuprel (isoproterenol)." Sanofi Winthrop Pharmaceuticals
- (2022) "Product Information. Epifrin (EPINEPHrine ophthalmic)." Allergan Inc
- (2022) "Product Information. Adrenalin (EPINEPHrine)." Apothecon Inc
- (2001) "Product Information. Levophed Bitartrate (norepinephrine)." Sanofi Winthrop Pharmaceuticals
Switch to consumer interaction data
Norisodrine with Calcium Iodine drug interactions
There are 435 drug interactions with Norisodrine with Calcium Iodine (anhydrous calcium iodide / isoproterenol).
Norisodrine with Calcium Iodine alcohol/food interactions
There is 1 alcohol/food interaction with Norisodrine with Calcium Iodine (anhydrous calcium iodide / isoproterenol).
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.